Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis

African Americans (AAs) and obese individuals have increased thrombotic risk. This study evaluated the effectiveness and safety of rivaroxaban versus warfarin in obese, AAs with nonvalvular atrial fibrillation (NVAF) or venous thromboembolism (VTE). Optum® De-Identified Electronic Health Record (EHR...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Olivia S., Beyer-Westendorf, Jan, Ashton, Veronica, Milentijevic, Dejan, Moore, Kenneth Todd, Bunz, Thomas J., Coleman, Craig I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588768/
https://www.ncbi.nlm.nih.gov/pubmed/33085526
http://dx.doi.org/10.1177/1076029620954910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588768/
https://www.ncbi.nlm.nih.gov/pubmed/33085526
http://dx.doi.org/10.1177/1076029620954910

Ejemplares similares